The Carlyle Group Inc. (CG)
| Market Cap | 17.83B |
| Revenue (ttm) | 4.74B |
| Net Income (ttm) | 1.02B |
| Shares Out | 357.68M |
| EPS (ttm) | 2.77 |
| PE Ratio | 18.00 |
| Forward PE | 11.79 |
| Dividend | $1.40 (2.81%) |
| Ex-Dividend Date | Feb 21, 2025 |
| Volume | 2,518,854 |
| Open | 51.94 |
| Previous Close | 51.66 |
| Day's Range | 49.45 - 52.13 |
| 52-Week Range | 36.65 - 57.50 |
| Beta | 1.69 |
| Analysts | Buy |
| Price Target | 54.57 (+9.45%) |
| Earnings Date | Feb 11, 2025 |
About CG
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid ventu... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for CG stock is "Buy." The 12-month stock price forecast is $54.57, which is an increase of 9.45% from the latest price.
News
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.
NEW YORK , Feb. 21, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by bluebird bio, Inc. (NASDAQ: BLUE) and its board of directors concerning the proposed ac...
bluebird bio Stock Alert - Kehoe Law Firm, P.C. Investigating the Fairness and Adequacy of the Proposed Acquisition of bluebird bio by Investment Firms in Collaboration with Biotech Execs
PHILADELPHIA, PA / ACCESS Newswire / February 21, 2025 / Kehoe Law Firm, P.C. is investigating potential claims on behalf of investors of bluebird bio (NASDAQ:BLUE) regarding the adequacy and fairness...
Bluebird bio to be taken private by Carlyle and SK Capital amid cash crunch
Gene therapy maker Bluebird bio said on Friday it would be taken private by Carlyle and SK Capital Partners, ending its tumultuous journey in the public markets as it struggled with a severe cash crun...
bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital
SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment ...
Higher Fee Revenues, Brighter Outlook Boost Mood Of Private Equity's Big 4
Record revenues from management fees and a brighter outlook for M&A in the year ahead helped private equity's Big Four close 2024 on a high note. The average net positivity score for the four largest ...
Acentra Health Employees Provide Over 3,000 Hours of Volunteer Work to Promote Healthier Communities
MCLEAN, Va., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial health...
The Search For 7% Investment Grade Yields, Part 2: Carlyle And Its Baby Bond
Equity is currently overvalued; we're increasing fixed-income exposure, focusing this time on investment-grade long-duration issues offering 7% yields. Carlyle Group, with an A- credit rating, has sol...
Farmfront Announces Commercial Partnership with BF Group to Supply Irrigation Solutions
MILAN--(BUSINESS WIRE)--Farmfront Group (“Farmfront”), a leading global platform of irrigation providers backed by global investment firm Carlyle (NASDAQ: CG), announces that it has signed a strategic...
The old economy is still very much out of favor right now, says Carlyle's Jeff Currie
Jeff Currie, Carlyle chief strategy officer of energy pathways, joins 'Squawk Box' to discuss impact of President Trump's tariffs on commodities, impact of steel and aluminum tariffs on producer infla...
Carlyle Group enters Indian auto parts industry with Highway-Roop platform buy
U.S.-based investment firm Carlyle Group has entered India's auto components market by buying a controlling stake in an entity formed by the combination of Indian auto parts companies Highway Industri...
The Carlyle Group Inc. (CG) Q4 2024 Earnings Call Transcript
The Carlyle Group Inc. (NASDAQ:CG) Q4 2024 Earnings Conference Call February 11, 2025 8:30 AM ET Company Participants Daniel Harris - Head of Investor Relations Harvey Schwartz - Chief Executive Offi...
Carlyle's slower fee growth draws questions as private-equity firm's stock falls
Carlyle Group Inc.'s stock fell 5% on Tuesday after the private-equity firm signaled a slowdown in its fee-related earnings growth in 2025, as it leans on its private-credit arm to increase its profit...
Carlyle's profit misses estimates as private equity business weighs
Carlyle Group's distributable fourth-quarter earnings missed market expectations on Tuesday, eclipsing a strong growth in the alternative asset manager's capital market business and sending its shares...
Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair
Acentra Health welcomes noted public sector health leaders Calder Lynch and Jami Snyder to its healthcare advisory board; appoints Julie Boughn as chair.
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 millio...
Entertainment 360 Receives Strategic Investment from Carlyle
LOS ANGELES , Jan. 29, 2025 /PRNewswire/ -- Entertainment 360, one of the world's premier talent management companies, announced today that it would be receiving an investment from global investment f...
Private Equity Investment In Japan Soars
Japan's share of all private equity and venture capital investments in Asia-Pacific grew in 2024 as the value of private equity deals targeting Japanese companies surged. Momentum is expected to conti...
Acentra Health Appoints Ezmeralda Sager as Chief Transformation Officer
MCLEAN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial health...
Carlyle lines up bankers for possible sale of British fund network Calastone, sources say
Carlyle has lined up bankers to explore a sale of its British funds network and data business Calastone, which would be the latest deal in a sector that has attracted billions of pounds from investors...
Carlyle Group: Alternative Assets With Stellar Management
Carlyle Group, led by CEO Harvey Schwartz, is well-positioned for long-term success with robust fundraising, strong leadership, and growing fee-related earnings. The firm has achieved record assets un...
Carlyle agrees to sell Italy's Forgital to Stonepeak
Private equity firm Carlyle has agreed to sell Italian firm Forgital, which manufactures forged components mainly for the aerospace sector, to U.S. alternative investment firm Stonepeak, the two compa...
Stonepeak to Acquire Forgital Group from Carlyle
NEW YORK & VELO D'ASTICO, Italy--(BUSINESS WIRE)--Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, today announced that it has entered into a definitive...
Carlyle's Jenkins on $5.7B Capital Raise, Credit Market
Mark Jenkins, Carlyle's head of global credit, discusses Carlyle raising $5.7 billion for its latest flagship credit fund and the outlook for the credit market. Speaking with Sonali Basak on Bloomberg...
Bank Of America Raises Bullish Outlook On US Brokers, Exchanges, Alternative Investments: 3 Top Picks For 2025
Bank of America is bullish on U.S. brokers, asset managers and exchanges heading into 2025, raising price targets across the sector by an average of 14%, citing strong tailwinds from deregulation, ris...
Acentra Health's Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety Organization
MCLEAN, Va., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial health...